Audra Reed's Contact Details

Audra Reed's Company Details

DxBilling Now

N/A, N/A, us • 5 - 9 Employees
BioTech/Drugs

◎ Designed for Start Up Diagnostics.◎ Pay for Only what you need◎ Strategic Data to Guide your Financial DecisionsNavigating the reimbursement options within the specialty diagnostic lab space may be daunting and confusing. Our approach is simple. We offer low-cost billing services which allow you to spend resources on the more costly elements of commercialization. Revenue Cycle Management (RCM) in molecular diagnostics is more than billing and collections. It is important for your RCM provider to understand the complexities and drivers that support your strategic decisions. We work with your consultants, partners, and management team to provide for a successful long-term enterprise. DxBilling Now provides the flexibility to give you specifically what YOU need.Bottom LineYou pay only for what you need.Customize our modules and multi-tiered products to fit your needs.The best part - long-term contracts are not required.◎ By using agile workflow, DxBilling Now is able to help you establish a reliable income stream based on accurate and timely claims activity.◎ Bottom line: Typically, DxBilling Now pricing comes in at a small percentage of the major RCM services in the specialty and genetic diagnostic sector.KnowledgableStay ahead of the ever-changing landscape in molecular diagnostics. It's important to engage consultants, attorneys, and industry advisory who understand the regulatory, financial, reporting, and coding issues unique to molecular diagnostics by leveraging DxBilling Now's network of consultants.DxBilling Now collaborates with a broad network of consultants and industry experts to assure we're staying ahead of the changesClient Customized reportsDxBilling Now's customizable analytics gives you usable and financially focused data.Custom reports can be added to your services in days vs months.